Articles

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy

Division of Hematology, Mayo Clinic, Rochester, Minnesota; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Kansas City
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, Iowa
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Internal Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona
Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, Iowa
Division of Hematology, Mayo Clinic, Rochester, Minnesota
Haematologica Early view Jan 18, 2024 https://doi.org/10.3324/haematol.2023.284704